SIGMA-VB: Validity and reliability of the Brazilian Portuguese version of the Montgomery-Åsberg Depression Rating Scale using the Structured Interview Guide for the MADRS.
Adolescent
Adult
Aged
Brazil
Cross-Cultural Comparison
Depression
/ diagnosis
Depressive Disorder, Major
/ diagnosis
Female
Humans
Interview, Psychological
/ methods
Male
Middle Aged
Psychiatric Status Rating Scales
/ standards
Reproducibility of Results
Sensitivity and Specificity
Surveys and Questionnaires
Translating
Young Adult
Journal
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
ISSN: 1809-452X
Titre abrégé: Braz J Psychiatry
Pays: Brazil
ID NLM: 100895975
Informations de publication
Date de publication:
Historique:
received:
22
03
2018
accepted:
11
08
2018
pubmed:
21
2
2019
medline:
4
9
2019
entrez:
21
2
2019
Statut:
ppublish
Résumé
The Montgomery-Åsberg Depression Rating Scale (MADRS) is widely used to assess depression severity. The Structured Interview Guide for the MADRS (SIGMA) was created to standardize MADRS assessment. The objective of this study was to translate and validate the original SIGMA into a Brazilian Portuguese version (SIGMA-VB). We translated and cross-culturally validated the original SIGMA into the SIGMA-VB, and assessed its psychometric properties using data from 93 adult outpatients enrolled in the Integral Assessment in Unipolar Depression (AIUNI) trial. Participants were assessed by two raters on five visits over 8 weeks. We calculated multiple interrater reliability indexes for the SIGMA-VB and used the Hamilton Depression Hating Scale (HAM-D) for validation purposes. According to the SIGMA-VB, participants had moderate depression at baseline followed by mild depression at 8 weeks. We found over 90% of correlation between scores attributed by different raters using the SIGMA-VB. Correlations between the SIGMA-VB and the HAM-D were above 66%. Our findings confirm that the SIGMA-VB is a valid and reliable instrument to assess depression severity in clinical research and practice. Its interrater reliability was similar to that of a previously published Japanese version of the SIGMA.
Identifiants
pubmed: 30785536
pii: S1516-44462019005003102
doi: 10.1590/1516-4446-2018-0105
pmc: PMC6804310
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
297-302Références
J Affect Disord. 2011 Jan;128(1-2):175-7
pubmed: 20696481
J Psychiatr Res. 2009 Aug;43(12):1049-56
pubmed: 19344914
Schweiz Arch Neurol Psychiatr (1985). 1988;139(2):51-65
pubmed: 2455937
Int J Methods Psychiatr Res. 2013 Sep;22(3):175-84
pubmed: 24038301
J Affect Disord. 2016 Aug;200:111-8
pubmed: 27130960
Hum Psychopharmacol. 2004 Apr;19(3):187-92
pubmed: 15079853
Int Clin Psychopharmacol. 2004 May;19(3):157-60
pubmed: 15107658
Br J Psychiatry. 2008 Jan;192(1):52-8
pubmed: 18174510
Br J Psychiatry. 1987 Jun;150:797-800
pubmed: 3651734
Acta Psychiatr Scand Suppl. 1987;334:1-100
pubmed: 2887090
Br J Psychiatry. 1982 Jul;141:45-9
pubmed: 7116071
Acta Neuropsychiatr. 1999 Mar;11(1):34-7
pubmed: 26976104
Eur Neuropsychopharmacol. 2006 Dec;16(8):601-11
pubmed: 16769204
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Am J Psychiatry. 2004 Dec;161(12):2163-77
pubmed: 15569884
Health Qual Life Outcomes. 2015 Apr 02;13:42
pubmed: 25889742
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Med Clin (Barc). 2002 Apr 13;118(13):493-9
pubmed: 11975886
Acta Psychiatr Scand. 1991 Aug;84(2):167-73
pubmed: 1950612
J Affect Disord. 2014 Jan;152-154:530-3
pubmed: 24144585
J Clin Psychopharmacol. 2005 Apr;25(2):105-10
pubmed: 15738740
J Affect Disord. 2010 Mar;121(3):268-72
pubmed: 19660815
BMC Psychiatry. 2015 Aug 19;15:200
pubmed: 26286597
J Affect Disord. 2017 Mar 01;210:287-293
pubmed: 28068617
Neuropsychiatr Dis Treat. 2016 Mar 07;12:603-7
pubmed: 27022265
Acta Psychiatr Scand. 1986 May;73(5):544-8
pubmed: 3751660
Asian J Psychiatr. 2017 Aug;28:41-46
pubmed: 28784395
Rev Colomb Psiquiatr. 2016 Jul-Sep;45(3):146-55
pubmed: 27569008
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131